Fragmentation in Healthcare: Who's to Blame?

In my last article, I explained why fragmentation is a big issue for everyone, especially patients, who end up with poor and costly care. If you missed it, you can read it here.

This time let's talk about how everyone, hospitals, doctors, patients, and the pharmaceutical industry, plays a part in making the problem worse. The real issue starts when no one wants to take responsibility, and instead, everyone just points the finger at everyone else. To stop the blame game, let's understand what's causing this fragmentation in the first place.

Fragmentation in healthcare happens when we focus on parts of the system without thinking about how they fit together.

It's often an unintended result of good intentions. Sounds complicated? Let's break it down for each stakeholder.

Hospitals and Doctors: The Best-of-Breed and Interoperability Dilemma

With enough funding, doctors often go for best-of-breed clinical systems for specific patient groups. These systems are great for specialized needs but can lead to major fragmentation.

Each department or specialty within a hospital may choose its own system without thinking about how it will work with others. This results in a patchwork of disconnected systems that don't talk to each other. It's a self-inflicted wound.

And when budgets are tight, doctors become creative and start digital projects that pharma companies can't resist funding, especially if their competitors have already pledged support. This dynamic leads to further fragmentation as hospitals and doctors adopt more systems and tools that they wouldn't be able to afford otherwise. To clean up the mess, hospital CIOs must invest heavily in integration efforts, using up resources that could be better spent on value-adding services for patients or better collaboration with external stakeholders.

Despite addressing all the technical hurdles, the focus on interoperability standards and policies still fails to drive more stakeholder collaboration.

Pharmaceutical Companies: Siloed Strategies and Fragmented Outcomes

Pharmaceutical companies, without meaning to, play a big role in healthcare fragmentation. While their substantial spending on marketing, medical education, and digital initiatives aims to differentiate products in a competitive landscape, it inadvertently contributes to a disjointed healthcare ecosystem.

Let me give you some examples:

• Siloed professional and patient portals requiring significant investments and resources to develop and maintain, with separate logins and passwords for each and every platform/company.
• Omnichannel marketing strategies flooding customers' inboxes to drive them into siloed medical education platforms, events, and congresses to justify investments through "adoption".
• Sponsoring healthcare providers' projects to maintain good prescriber relationships and drive product sales, but with little regard for the projects' long-term viability.

From an inside-out perspective, these omnichannel strategies effectively meet internal KPIs, meticulously dissected and analyzed by an army of data scientists. However, focusing on these isolated metrics and short-term targets rather than the bigger picture leads to unintended consequences; healthcare professionals often feel overwhelmed by the sheer volume of disjointed messages and platforms from various product teams and companies. This results in bad customer experiences. Digital fatigue sets in, ultimately making it harder to reach customers and reducing the chances of messages cutting through the noise. This is how pharma companies unintentionally perpetuate the fragmentation they could help resolve.

Patients: Unwitting Contributors to Fragmentation

Patients often view themselves as victims of the healthcare system, frequently pointing to rising premiums and blaming the pharmaceutical industry. However, they unknowingly also play an important role in healthcare fragmentation through their behaviors and choices.

1. Overconsumption of Services: Many patients, especially those with comprehensive insurance, feel the need to get their money's worth. This leads to unnecessary doctor visits, tests, and treatments, even for minor issues that could be handled at home.
2. Demand for Expensive Care: There's a common belief that more expensive care means better care. Patients often insist on seeing specialists or undergoing costly procedures when simpler, less expensive options might work just as well.
3. Lack of Coordination: Patients often seek care from multiple providers without a centralized point of coordination. This can lead to redundant tests, conflicting diagnoses, and fragmented treatment plans.
4. Information Silos: Patients sometimes fail to share complete medical histories or details about treatments from other providers, creating information gaps that contribute to fragmentation.
5. Misunderstanding of Healthcare Needs: Many patients don't know how to differentiate between necessary and unnecessary care, leading to overuse of healthcare services.

These behaviors collectively contribute to what some experts estimate to be up to 50% waste in healthcare spending. By focusing on individual needs without considering the broader impact, patients unintentionally sustain and worsen the fragmented nature of the healthcare system.

Conclusion: The Fragmentation Puzzle and the Path Forward

I'm not blaming patients here, but it's important to recognize their role in the complex healthcare system. Patient behavior is both a symptom and a cause of fragmentation, showing the broader issue while also adding to them.

As we've seen, healthcare fragmentation is a complex issue with multiple contributors. Hospitals and doctors, in their pursuit of specialized excellence, often create disconnected systems. Pharmaceutical companies, focused on product-specific goals, inadvertently sustain a fragmented ecosystem through uncoordinated spending and siloed strategies. Patients, often unaware of their impact, contribute through overconsumption and uncoordinated care-seeking behaviors.

The root of the problem lies in the misalignment of goals and the lack of a coherent, overarching strategy. Each stakeholder operates within their own silo, focusing on immediate effects and individual KPIs rather than the long-term sustainability and efficiency of the healthcare system as a whole.

This fragmentation isn't the result of malicious intent, but rather the unintended consequence of well-meaning actions viewed through narrow lenses. The challenge lies in shifting from a fragmented approach to a holistic view of healthcare.

In the final article of this series, I'll explore potential solutions to this fragmentation puzzle. We'll look at how aligning strategies across stakeholders, rethinking KPIs, and fostering collaboration could lead to a more integrated, efficient, and patient-centered healthcare system.

Stay tuned as we move from diagnosing the problem to envisioning a path forward. The journey towards defragmenting healthcare is complex, but with a shared understanding and collective effort, positive change is possible. Looking forward to your comments!

---

An earlier version of this article first appeared on LinkedIn.